By Dirk Hoffman
Published October 30, 2026
Steven J. Fliesler, PhD, SUNY Distinguished Professor and Meyer H. Riwchun Endowed Chair Professor of ophthalmology in the Jacobs School of Medicine and Biomedical Sciences, has been honored with The Francis Crick Award Lecture in Neuroscience and Medicine for 2026 at Louisiana State University Health New Orleans.
The Francis Crick Award Lecture recognizes individuals whose scientific achievements have had a significant and lasting impact on biomedical research.
The award lecture is part of a series that has become a tradition since the first one presented in 1985 by the late Francis Crick, PhD, best known for co-discovering the double helix structure of DNA. Sixteen Nobel laureate scientists have delivered related lectures of the series.
Fliesler was presented the award by Nicolas G. Bazan, MD, PhD, Boyd Professor and director of the LSU’s Neuroscience Center of Excellence; and David S. Guzick, MD, PhD, senior vice chancellor for LSU Health Sciences Center New Orleans.
“Dr. Fliesler was selected for his exceptional, creative, sustained contributions to vision science, neuroscience, and retinal biology,” Bazan says. “Over the course of a distinguished career spanning several decades, he has advanced our understanding of cholesterol metabolism in the retina, mechanisms underlying retinal degenerative diseases, and the biochemical foundations of visual function.”
Bazan says Fliesler’s work has been characterized by “scientific rigor, originality, and a commitment to mentoring future generations of investigators.”
“His body of work, leadership in the field, and influence on colleagues and trainees alike make him especially deserving of this honor.”
Fliesler was previously honored by LSU Health New Orleans with the 2023 Chancellor’s Award Lecture in Neuroscience and Ophthalmology, and in 2017 with the Dean’s Award in Neuroscience and Ophthalmology.
Regarding LSU’s previous recognitions, Bazan says that each acknowledged different aspects of Fliesler’s contributions and accomplishments at specific moments in his career.
“While the honors are distinct, they share a common theme: recognition of his outstanding scientific achievements, leadership, and enduring influence on vision research and neuroscience,” he says.
Bazan, who is an internationally recognized leader in the field of lipid metabolism, particularly as concerns the retina and brain, has known Fliesler since he was a graduate student at Rice University.
“What has always stood out to me is not only his scientific excellence but also his intellectual curiosity, integrity, humility, and generosity toward colleagues and trainees,” Bazan says. “These qualities, combined with his unwavering dedication to discovery, have earned him the respect and admiration of the scientific community.”
“Steve exemplifies the highest standards of scholarship and professional conduct. His career has left an indelible mark on vision science and biomedical research, and I can think of no one more deserving of this recognition.”
Fliesler says Bazan has served as a highly valued and generous mentor to him over the years.
“He was highly instrumental in my being chosen for this award. He has followed (and selflessly promoted) my career ever since I was a graduate student, even though we have never worked together or co-published.”
Fliesler says he was “stunned” to learn he was chosen to receive the prestigious Francis Crick Award.
“I am truly honored and thankful for this singular accolade,” he says. “It is probably the highest academic honor that I’ve received in my entire professional career.”
Fliesler delivered his lecture, titled “Keeping an Eye on Cholesterol Pathway Defects Affecting the Eye: Lessons from Animal Model Studies,” Oct. 14 at the Neuroscience Center of Excellence, School of Medicine, LSU Health New Orleans.
He says he chose the topic of cholesterol and its role in the retina because his lab has been focused on this area of study for nearly four decades.
Fliesler says at the outset, he and his fellow researchers were not focused on a particular disease entity.
Instead, they set out to address three fundamental biological questions:
“As it turns out, relevant to the third question, there are several hereditary human diseases caused by the inability to synthesize cholesterol and that result in severe pathology,” Fliesler says. “However, the impact on retinal development, structure and function have not been well studied. We developed some novel experimental animal models in order to answer the questions we originally posed.”
One of the models mimics the biological defect as observed in humans who are afflicted with Smith-Lemli-Opitz Syndrome (SLOS).
“We found that cholesterol deficiency and replacement of cholesterol by its immediate biogenic precursor (7-dehydrocholesterol, or 7DHC) results in profound defects in retinal structure and function,” Fliesler says. “But the remedy was not merely providing exogenous dietary cholesterol; full ‘rescue’ of the pathological features required antioxidants in addition.”
“Hence, what started out initially as just a quest to answer some fundamental biological questions ended up having potentially significant ‘translational’ outcomes that we think could be informative toward developing a novel and more effective therapeutic intervention for SLOS.”
Fliesler serves as vice-chair and director of research in the Department of Ophthalmology in the Jacobs School. He also holds concurrent appointments as a professor in the Department of Biochemistry and in the Neuroscience Program at the Jacobs School, as well as being a Research Career Scientist at the Buffalo VA Medical Center (VA Western NY Healthcare System).
He earned his bachelor’s degree in biochemistry from the University of California, Berkeley, and his doctorate in biochemistry from Rice University. He then completed a postdoctoral fellowship studying retinal biochemistry at Baylor College of Medicine. Fliesler joined the Jacobs School faculty in 2008. Before coming to UB, he was a longtime faculty member at Saint Louis University.